News
Local
Sports
Business
Entertainment
Lifestyle
Opinion
Real Estate News
Hot Property
eNewspaper
________________
Subscriptions
Manage Subscription
EZPay
Delivery Issue
eNewspaper
Subscribe
Subscriber Terms
Gift Subscription Terms
Manage Subscription
EZPay
Delivery Issue
eNewspaper
Subscribe
Subscriber Terms
Gift Subscription Terms
About Us
Contact us
Our Journalism Explained
Newsletters
Readers Rep
Careers
Events
Historical Archives
Podcasts and Livestreams
U-T Store
Contact us
Our Journalism Explained
Newsletters
Readers Rep
Careers
Events
Historical Archives
Podcasts and Livestreams
U-T Store
Events
Advertising
Place an ad
Media kit
Rate book
Report an ad problem
Cars
Classifieds
Eldercare Directory
Jobs
Newspaper ad directory
Newspaper special sections
Real Estate
Sponsored
Stats Digital
Place an ad
Media kit
Rate book
Report an ad problem
Cars
Classifieds
Eldercare Directory
Jobs
Newspaper ad directory
Newspaper special sections
Real Estate
Sponsored
Stats Digital
Jobs
CaregiverSD
Community papers
Del Mar Times
Encinitas Advocate
La Jolla Light
PB Monthly
Point Loma-OB Monthly
Pomerado News
Poway News Chieftain
Ramona Sentinel
Rancho Bernardo
Rancho Santa Fe Review
Del Mar Times
Encinitas Advocate
La Jolla Light
PB Monthly
Point Loma-OB Monthly
Pomerado News
Poway News Chieftain
Ramona Sentinel
Rancho Bernardo
Rancho Santa Fe Review
Games, Puzzles, and Crossword
Crossword
Sudoku
Crossword
Sudoku
Obituaries
Death Notices
Place an obituary
Death Notices
Place an obituary
U-T En Español
Deportes
Comunidad
Espectáculos
Cierre de Edición, fotos, videos
Noticias
Deportes
Comunidad
Espectáculos
Cierre de Edición, fotos, videos
Noticias
Privacy and Terms
Privacy
Terms
Advertising terms
Privacy
Terms
Advertising terms
Copyright © 2022, The San Diego Union-Tribune |
CA Notice of Collection
|
Do Not Sell My Personal Information
Sections
Sports
Business
Entertainment
Lifestyle
Opinion
Real Estate
Obituaries
eNewspaper
Newsletters
Show Search
Search Query
Submit Search
COVID-19
For subscribers
Phenomenal women
Latino life
Crossword
Sudoku
About Us
Contact us
Community Advisory Board
Readers Rep
Careers
Events
Historical Archives
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude+Oil
Local Stocks
San Diego Stocks
San Diego Stocks
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Aquestive Therapeutics, Inc. - Common Stock
(NQ:
AQST
)
4.160
-0.180 (-4.15%)
Streaming Delayed Price
Updated: 4:00 PM EDT, May 12, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Aquestive Therapeutics, Inc. - Common Stock
< Previous
1
2
3
4
5
Next >
Aquestive (AQST) Q4 2025 Earnings Call Transcript
↗
March 05, 2026
Aquestive (AQST) Q4 2025 Earnings Call Transcript
Via
The Motley Fool
Topics
Earnings
Lawsuit
Aquestive Therapeutics Inc (NASDAQ:AQST) Reports Mixed Q4 2025 Results and Anaphylm Regulatory Update
↗
March 04, 2026
Via
Chartmill
Top movers in Monday's session
↗
February 02, 2026
Via
Chartmill
Check out the stocks that are attracting the most attention and driving market activity.
↗
February 02, 2026
Via
Chartmill
Why Did AQST Stock Plunge 40% In Pre-Market Today?
↗
January 09, 2026
Via
Stocktwits
Earnings Scheduled For November 5, 2025
↗
November 05, 2025
Via
Benzinga
Aquestive Stock Jumps After-Hours As CEO Sees $1B ‘Blockbuster’ Potential For Oral Allergy Film — Retail Sees Stock As Buyout Candidate
↗
September 26, 2025
Via
Stocktwits
FDA Says No Advisory Committee Meeting Needed For Aquestive’s Oral Epinephrine Film
↗
September 04, 2025
Via
Stocktwits
Monday's session: top gainers and losers
↗
February 02, 2026
Via
Chartmill
Monday's session: gap up and gap down stocks
↗
February 02, 2026
Via
Chartmill
Why Did AQST Stock Jump 35% Today?
↗
February 02, 2026
The company received a Complete Response Letter from the U.S. Food and Drug Administration for its New Drug Application seeking approval of Anaphylm, a sublingual film to treat severe Type I allergic...
Via
Stocktwits
Monday's pre-market session: top gainers and losers
↗
February 02, 2026
Via
Chartmill
What's going on in today's session
↗
January 09, 2026
Via
Chartmill
Keep an eye on the top gainers and losers in Friday's session.
↗
January 09, 2026
Via
Chartmill
The market is filled with gapping stocks in Friday's session.
↗
January 09, 2026
Via
Chartmill
Friday's pre-market session: top gainers and losers
↗
January 09, 2026
Via
Chartmill
Small-Cap Renaissance: Russell 2000 Scales New Heights While Big Tech Stumbles
January 08, 2026
In a dramatic shift that has recalibrated the pulse of Wall Street, the Russell 2000 index (RUT) surged to a new record high on January 8, 2026, signaling a definitive breakout for small-cap stocks. As...
Via
MarketMinute
Topics
Artificial Intelligence
Economy
Intellectual Property
Small-Cap Slump: Russell 2000 Tumbles as Sticky Inflation Data Revives 'Higher-for-Longer' Fears
January 07, 2026
The Russell 2000 index, the primary benchmark for American small-cap stocks, suffered a significant sell-off on Wednesday, January 7, 2026, as a batch of conflicting economic data sparked fears that...
Via
MarketMinute
Topics
Artificial Intelligence
Economy
Stocks
Jim Cramer: Joby Is 'Losing Too Much Money'
↗
November 12, 2025
Jim Cramer finds Aquestive Therapeutics very interesting, while Amphenol Corporation is a great stock. Joby Aviation is losing money.
Via
Benzinga
Friday's session: gap up and gap down stocks
↗
September 26, 2025
Let's have a look at the gap up and gap down stocks in today's session.
Via
Chartmill
Crinetics Pharmaceuticals, BlackBerry, Perpetua Resources And Other Big Stocks Moving Higher On Friday
↗
September 26, 2025
U.S. stocks were higher, with the Dow Jones index gaining more than 200 points on Friday. Shares of Crinetics Pharmaceuticals, Inc. (NASDAQ: CRNX) rose sharply during Friday's session after the FDA...
Via
Benzinga
Topics
Stocks
ARS Pharma Urges FDA To Delay Approval Of Aquestive's Allergic Reaction Treatment
↗
September 23, 2025
ARS Pharmaceuticals petitioned the FDA to delay approval of Aquestive's epinephrine film, citing safety, dosing, and cardiovascular concerns.
Via
Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
↗
September 19, 2025
Via
Benzinga
CoreWeave, Barrick Mining, FedEx And Other Big Stocks Moving Higher On Friday
↗
September 19, 2025
Via
Benzinga
Which stocks are gapping on Friday?
↗
September 19, 2025
The market is filled with gapping stocks in Friday's session. Let's discover which stocks are showing gap-ups and gap-downs.
Via
Chartmill
12 Health Care Stocks Moving In Thursday's Intraday Session
↗
September 04, 2025
Via
Benzinga
Shoe Carnival, American Eagle, Ciena, Victoria's Secret And Other Big Stocks Moving Higher On Thursday
↗
September 04, 2025
Via
Benzinga
FDA Confirms Direct Review Path For Aquestive's Allergy Treatment
↗
September 04, 2025
Aquestive's Anaphylm could become the first oral epinephrine for severe allergic reactions after the FDA set a 2026 decision date without panel review.
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
↗
September 04, 2025
Via
Benzinga
10 Health Care Stocks Whale Activity In Today's Session
↗
August 14, 2025
Via
Benzinga
< Previous
1
2
3
4
5
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.